Bacille Calmette-Guerin vaccine induced lymphadenitis in infants and children masquerading with tubercular lymphadenitis at tertiary care hospital in North India
Background: Bacille calmette–guerin (BCG) vaccine containing live-attenuated Mycobacterium bovis was first used in humans to prevent tuberculosis in 1921. It is a safe vaccine. However, there can be minor adverse reactions such as pain, swelling, and redness at local injection site. The lesser known...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Eldaghayes Publisher
2022-10-01
|
| Col·lecció: | National Journal of Physiology, Pharmacy and Pharmacology |
| Matèries: | |
| Accés en línia: | http://www.ejmanager.com/fulltextpdf.php?mno=96846 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|